OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 42 citing articles:

Surveillance of Invasive Pneumococcal Disease in Spain Exploring the Impact of the COVID-19 Pandemic (2019-2023)
Covadonga Pérez-García, Julio Sempere, Sara de Miguel, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106204-106204
Open Access | Times Cited: 18

The latest news in France before distribution of third-generation pneumococcal conjugate vaccines
Robert Cohen, Corinne Lévy, Emmanuelle Varon
Infectious Diseases Now (2024) Vol. 54, Iss. 5, pp. 104937-104937
Open Access | Times Cited: 8

Community acquired pneumonia due to antibiotic resistant-Streptococcus pneumoniae: diagnosis, management and prevention
Grace Lui, Christopher K.C. Lai
Current Opinion in Pulmonary Medicine (2025)
Closed Access

Modelling the Epidemiological Impact of Different Adult Pneumococcal Vaccination Strategies in the United Kingdom
Rachel J. Oidtman, Giulio Meleleo, Oluwaseun Sharomi, et al.
Infectious Diseases and Therapy (2025)
Open Access

Pneumococcal-13-valent-CRM197-vaccine-conjugate

Reactions Weekly (2025) Vol. 2045, Iss. 1, pp. 354-354
Closed Access

Global distribution and characteristics of pneumococcal serotypes in adults
Haruka Maeda, Konosuke Morimoto
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access

Childhood invasive pneumococcal disease and acute otitis media in Central Greece during 2005-2024 – A report at the doorstep of the new multivalent PCV era
George A. Syrogiannopoulos, Aspasia N. Michoula, Maria Moriondo, et al.
Vaccine (2025), pp. 126765-126765
Closed Access

Pneumonia-Related Hospitalizations among the Elderly: A Retrospective Study in Northeast Italy
Silvia Cocchio, Claudia Cozzolino, Patrizia Furlan, et al.
Diseases (2024) Vol. 12, Iss. 10, pp. 254-254
Open Access | Times Cited: 3

Pneumococci Isolated From Children in Community-Based Practice Differ From Isolates Identified by Population- and Laboratory-Based Invasive Disease Surveillance
Ravinder Kaur, Ryan Gierke, Lesley McGee, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1243-1252
Closed Access | Times Cited: 2

Pneumococcal carriage and disease in adults in England 2011-2019: the importance of adults as a reservoir for pneumococcus in communities
Dima El Safadi, Lisa Hitchins, Ashleigh Howard, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 2

Memory B cell responses induced by pneumococcal conjugate vaccine schedules with fewer doses: analysis of a randomised-controlled trial in Viet Nam
Darren Suryawijaya Ong, Thanh Van Phan, Beth Temple, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Pneumococcal carriage in a large Sicilian sample population: impact on the current epidemiological scenario and implications for future vaccination strategies
Emanuele Amodio, Fabio Tramuto, Valerio De Francisci, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1

Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013–2023) and the role of serotype 3
Louise Lansbury, Tricia M. McKeever, Hannah Lawrence, et al.
Thorax (2024), pp. thorax-221976
Closed Access | Times Cited: 1

Will two doses of pneumococcal conjugate vaccine be enough?
Fiona M. Russell, Kulkanya Chokephaibulkit
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 5, pp. 449-451
Closed Access

Increased Incidence of Invasive Pneumococcal Disease in Hong Kong in 2023
Chrissy Wing Kwan Pang, Richard Vale, Kim Shijian Lao, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106178-106178
Closed Access

Enfermedad Neumocócica Invasiva en España en 2023
Marta Soler Soneira, Javier Del-Águila-Mejía, Marina Acosta-Gutiérrez, et al.
Boletín Epidemiológico Semanal (2024) Vol. 32, Iss. 2, pp. 74-93
Open Access

Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia
Claire von Mollendorf, Tuya Mungun, Munkhchuluun Ulziibayar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access

Supporting vaccine (co)-administration decisions: Development and validation of a tool for assessing the risk of severe outcomes due to lower respiratory tract infections
Francesco Lapi, Alexander Domnich, Ettore Marconi, et al.
Respiratory Medicine (2024) Vol. 232, pp. 107761-107761
Closed Access

New-generation pneumococcal vaccines for children
Philippe De Wals
The Lancet Public Health (2024) Vol. 9, Iss. 9, pp. e638-e639
Open Access

Assessing the Impact of Pneumococcal Conjugate Vaccine Immunization Schedule Change From 3+0 to 2+1 in Australian Children: A Retrospective Observational Study
Sanjay Jayasinghe, Phoebe Williams, Kristine Macartney, et al.
Clinical Infectious Diseases (2024) Vol. 80, Iss. 1, pp. 207-214
Closed Access

Page 1 - Next Page

Scroll to top